To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
Conditions
End-Stage Renal Disease Requiring Haemodialysis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Peking University People's Hospital, Beijing, Beijing Municipality, China
Study leads
Li Zuo, Doctor
Principal Investigator
Peking University People's Hospital
Yuqing Chen
Principal Investigator
Peking University First Hospital